MedPath

Evaluation of the effect of citric acid on UBT results in dyspeptic patients on PPI and positive H.Pylori

Phase 2
Conditions
dyspepsia.
Indigestion
Registration Number
IRCT201105221155N12
Lead Sponsor
Bidar Taban Ariya (BTA)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Age = 18 years ; Signed a consent form ; Detection of Helicobacter pylori infection ; start treatment with PPI
Exclusion criteria: The history of previous gastric surgery ; Antibiotics consumption during 4 weeks before the first UBT test or during the study period ; Participation in a clinical study during 30 days before the screening visit ; Other considerable clinical disorders that researcher postulates patient is not eligible Taking H2 blocker or PPI ; 2 weeks before the study, Pregnancy ; History of recent peptic ulcer and esophagitis ; Prior therapy ; History of chronic liver and renal disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rease breath test with administration 4g of citric acid. Timepoint: 2 days. Method of measurement: UBT.;Urease breath test without administration 4g of citric acid. Timepoint: 2 days. Method of measurement: UBT.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath